ArticleMaterials today. Bio2025

Synergistic HER2-scFv mediated immunotherapy with targeted gemcitabine delivery harnessing biomimetic composite nanoparticles for enhanced metastatic tumor therapy.

Xinan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.